USD 0.0
(-50.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 994.33 Thousand USD | -44.5% |
2022 | 1.79 Million USD | 235.94% |
2021 | 533.27 Thousand USD | 84.66% |
2020 | 288.78 Thousand USD | -41.27% |
2019 | 491.75 Thousand USD | -80.1% |
2018 | 2.47 Million CAD | 59.2% |
2017 | 1.55 Million CAD | 764.38% |
2016 | 179.56 Thousand CAD | -88.75% |
2015 | 1.59 Million CAD | 86.07% |
2014 | 858.2 Thousand CAD | -6.32% |
2013 | 916.11 Thousand CAD | 205.45% |
2012 | 299.92 Thousand CAD | 85.33% |
2011 | 161.82 Thousand CAD | 200.48% |
2010 | 53.85 Thousand CAD | 21.88% |
2009 | 44.18 Thousand CAD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 3.17 Million USD | 226.6% |
2023 Q1 | 1.22 Million USD | -31.48% |
2023 FY | 994.33 Thousand USD | -44.5% |
2023 Q2 | 1.12 Million USD | -7.97% |
2023 Q3 | 857.51 Thousand USD | -24.09% |
2023 Q4 | 994.33 Thousand USD | 15.96% |
2022 Q1 | 282.1 Thousand CAD | -47.1% |
2022 Q4 | 1.79 Million USD | 578.97% |
2022 FY | 1.79 Million USD | 235.94% |
2022 Q3 | 263.85 Thousand USD | -26.14% |
2022 Q2 | 357.22 Thousand CAD | 26.63% |
2021 Q1 | 393.51 Thousand CAD | 6.96% |
2021 Q2 | 342.1 Thousand CAD | -13.07% |
2021 Q3 | 459.36 Thousand CAD | 34.28% |
2021 Q4 | 533.27 Thousand CAD | 16.09% |
2021 FY | 533.27 Thousand USD | 84.66% |
2020 Q3 | 158.92 Thousand CAD | -67.21% |
2020 FY | 288.78 Thousand USD | -41.27% |
2020 Q1 | 1.05 Million CAD | 65.11% |
2020 Q2 | 484.64 Thousand CAD | -53.97% |
2020 Q4 | 367.9 Thousand CAD | 131.5% |
2019 Q3 | 5.05 Million CAD | 31.63% |
2019 Q2 | 3.83 Million CAD | 9.26% |
2019 FY | 491.75 Thousand USD | -80.1% |
2019 Q4 | 637.68 Thousand CAD | -87.38% |
2019 Q1 | 3.51 Million CAD | 4.09% |
2018 Q2 | 2.55 Million CAD | 23.24% |
2018 Q1 | 2.07 Million CAD | 11.33% |
2018 FY | 2.47 Million CAD | 59.2% |
2018 Q4 | 3.37 Million CAD | 0.66% |
2018 Q3 | 3.35 Million CAD | 31.37% |
2017 Q2 | 399.07 Thousand CAD | 26.31% |
2017 Q3 | 539.23 Thousand CAD | 35.12% |
2017 Q4 | 1.86 Million CAD | 244.99% |
2017 FY | 1.55 Million CAD | 764.38% |
2017 Q1 | 315.94 Thousand CAD | 31.2% |
2016 Q1 | 1.73 Million CAD | -15.66% |
2016 FY | 179.56 Thousand CAD | -88.75% |
2016 Q2 | 2.24 Million CAD | 29.21% |
2016 Q4 | 240.81 Thousand CAD | -86.28% |
2016 Q3 | 1.75 Million CAD | -21.73% |
2015 Q2 | 1.22 Million CAD | 23.13% |
2015 FY | 1.59 Million CAD | 86.07% |
2015 Q4 | 2.05 Million CAD | 6.08% |
2015 Q3 | 1.93 Million CAD | 58.05% |
2015 Q1 | 996.81 Thousand CAD | 16.15% |
2014 Q4 | 858.2 Thousand CAD | 13.49% |
2014 FY | 858.2 Thousand CAD | -6.32% |
2014 Q3 | 756.21 Thousand CAD | -5.15% |
2014 Q2 | 797.24 Thousand CAD | 719.54% |
2014 Q1 | 97.28 Thousand CAD | -89.38% |
2013 FY | 916.11 Thousand CAD | 205.45% |
2013 Q2 | 302.17 Thousand CAD | 0.0% |
2013 Q1 | - CAD | -100.0% |
2013 Q4 | 916.11 Thousand CAD | 574.66% |
2013 Q3 | 135.78 Thousand CAD | -55.06% |
2012 Q1 | 192.87 Thousand CAD | 19.18% |
2012 FY | 299.92 Thousand CAD | 85.33% |
2012 Q4 | 299.92 Thousand CAD | 18.52% |
2012 Q2 | 228.85 Thousand CAD | 18.65% |
2012 Q3 | 253.06 Thousand CAD | 10.58% |
2011 Q3 | 145.81 Thousand CAD | 73.5% |
2011 FY | 161.82 Thousand CAD | 200.48% |
2011 Q4 | 161.82 Thousand CAD | 10.98% |
2011 Q1 | 53.94 Thousand CAD | 0.17% |
2011 Q2 | 84.04 Thousand CAD | 55.78% |
2010 FY | 53.85 Thousand CAD | 21.88% |
2010 Q4 | 53.85 Thousand CAD | 0.0% |
2009 FY | 44.18 Thousand CAD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Allied Energy Corporation | 4.34 Million USD | 77.127% |
Igene Biotechnology, Inc. | 7.5 Million USD | 86.746% |
Lotus Bio-Technology Development Corp. | - USD | -Infinity% |
MagIndustries Corp. | 99.83 Million USD | 99.004% |
Itafos Inc. | 346.68 Million USD | 99.713% |
Potash America, Inc. | 2.33 Million USD | 57.354% |
Yara International ASA | 8.45 Billion USD | 99.988% |
Yara International ASA | 8.43 Billion USD | 99.988% |